Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors

被引:3
|
作者
Tolah, Ahmed M. [1 ,2 ]
Azhar, Esam I. [1 ,2 ]
Hashem, Anwar M. [2 ,3 ]
机构
[1] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah 21413, Saudi Arabia
[2] King Abdulaziz Univ, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah 21413, Saudi Arabia
[3] King Abdulaziz Univ, Dept Med Microbiol & Parasitol, Fac Med, Jeddah 21413, Saudi Arabia
关键词
OSELTAMIVIR; H1N1;
D O I
10.15537/smj.2016.4.14837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the sensitivity of circulating influenza viruses in Western Saudi Arabia to neuraminidase inhibitors (NAIs); mainly, zanamivir and oseltamivir. Methods: Respiratory samples were collected from patients presenting with respiratory symptoms to King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia (KSA) between September 2013 and October 2014. All samples were tested prospectively by real-time reverse-transcription polymerase chain reaction for influenza A and B viruses. Positive samples were then inoculated on Madin-Darby Canine Kidney (MDCK) cells and isolated viruses were examined for their sensitivity to NAIs using fluorescent neuraminidase inhibition assay. Results: Out of 406 tested samples, 25 samples (6.2%) were positive for influenza A/pdmH1N1 virus, one sample (0.25%) was positive for influenza A/H3N2 virus, and 7 samples (1.7%) were positive for influenza B Yamagata-like virus. Screening of isolated influenza A and B viruses (9 out of 33) for their sensitivity to NAIs showed no significant resistance to available NAIs. Conclusion: Our results show that circulating influenza viruses in Jeddah are still sensitive to NAIs.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 50 条
  • [21] Neuraminidase inhibitors resistance in influenza viruses - a current medical problem
    Nitsch-Osuch, Aneta
    Brydak, Lidia Bernadeta
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2009, 11 (02): : 203 - 209
  • [22] Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors
    Larisa Mochalova
    Rick Bright
    Xiyan Xu
    Elena Korchagina
    Alexander Chinarev
    Niсolai Bovin
    Alexander Klimov
    Glycoconjugate Journal, 2010, 27 : 321 - 327
  • [23] Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors
    Mochalova, Larisa
    Bright, Rick
    Xu, Xiyan
    Korchagina, Elena
    Chinarev, Alexander
    Bovin, Nicolai
    Klimov, Alexander
    GLYCOCONJUGATE JOURNAL, 2010, 27 (03) : 321 - 327
  • [24] Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes
    Hurt, A. C.
    Selleck, P.
    Komadina, N.
    Shaw, R.
    Brown, L.
    Barr, I. G.
    ANTIVIRAL RESEARCH, 2007, 73 (03) : 228 - 231
  • [25] Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017
    Lackenby, Angie
    Besselaar, Terry G.
    Daniels, Rod S.
    Fry, Alicia
    Gregory, Vicki
    Gubareva, Larisa V.
    Huang, Weijuan
    Hurt, Aeron C.
    Leang, Sook-Kwan
    Lee, Raphael T. C.
    Lo, Janice
    Lollis, Lori
    Maurer-Stroh, Sebastian
    Odagiri, Takato
    Pereyaslov, Dmitriy
    Takashita, Emi
    Wang, Dayan
    Zhang, Wenqing
    Meijer, Adam
    ANTIVIRAL RESEARCH, 2018, 157 : 38 - 46
  • [26] Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
    McSharry, JJ
    McDonough, AC
    Olson, BA
    Drusano, GL
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) : 21 - 28
  • [27] Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
    Leang, Sook-Kwan
    Kwok, Simon
    Sullivan, Sheena G.
    Maurer-Stroh, Sebastian
    Kelso, Anne
    Barr, Ian G.
    Hurt, Aeron C.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (02) : 135 - 139
  • [28] Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors
    Mishin, VP
    Novikov, D
    Hayden, FG
    Gubareva, LV
    JOURNAL OF VIROLOGY, 2005, 79 (19) : 12416 - 12424
  • [29] Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
    Abed, Yacine
    Fage, Clement
    Lague, Patrick
    Carbonneau, Julie
    Papenburg, Jesse
    Vinh, Donald C.
    Boivin, Guy
    EMERGING INFECTIOUS DISEASES, 2019, 25 (04) : 838 - 840
  • [30] Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses
    Farrukee, Rubaiyea
    Mosse, Jennifer
    Hurt, Aeron C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (11) : 1135 - 1145